Does long-term dual antiplatelet therapy with aspirin and clopidogrel improve secondary prevention in patients with ischemic stroke or TIA?
Long-term dual antiplatelet therapy with aspirin and clopidogrel is not supported by current evidence for widespread use in secondary stroke prevention.
Currently available evidence does not substantiate the widespread use of long-term aspirin with clopidogrel for the secondary prevention of ischemic stroke or TIA.
Davis et al. (Fri,) studied this question.